{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:04:10Z","timestamp":1790417050238,"version":"4.1.0"},"reference-count":41,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jfda.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T04:58:32Z","timestamp":1518584312000},"page":"S72-S77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"S","title":["Update of green tea interactions with cardiovascular drugs\u00a0and\u00a0putative mechanisms"],"prefix":"10.38212","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-1157","authenticated-orcid":false,"given":"Jos\u00e9 Pablo","family":"Werba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingen","family":"Misaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-8821","authenticated-orcid":false,"given":"Monica Gianna","family":"Giroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenju","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-1904","authenticated-orcid":false,"given":"Niccol\u00f2","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Vigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25385","reference":[{"key":"10.1016\/j.jfda.2018.01.008_bib1","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/molecules21121759","article-title":"Preventive effects of catechins on cardiovascular disease","volume":"21","author":"Chen","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jfda.2018.01.008_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jfda.2014.04.001","article-title":"Antioxidant effects of Camellia sinensis L. Extract in patients with type 2 diabetes","volume":"22","author":"Spadiene","year":"2014","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.jfda.2018.01.008_bib3","series-title":"The world medicines situation 2011, Pharmaceutical consumption","first-page":"1","author":"Hoebert","year":"2011"},{"key":"10.1016\/j.jfda.2018.01.008_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jfda.2015.04.008","article-title":"Recent trends in specialty pharma business model","volume":"23","author":"Ku","year":"2015","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.jfda.2018.01.008_bib5","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2174\/1381612820666141013135045","article-title":"Overview of green tea interaction with cardiovascular drugs","volume":"21","author":"Werba","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jfda.2018.01.008_bib6","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfda.2018.01.008_bib7","series-title":"National report on medicines use in Italy 2016","author":"The Medicines Utilization Monitoring Centre","year":"2017"},{"key":"10.1016\/j.jfda.2018.01.008_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.7326\/0003-4819-149-4-200808190-00019","article-title":"The effect of green tea on simvastatin tolerability","volume":"149","author":"Werba","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfda.2018.01.008_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/DDDT.S130050","article-title":"Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers","volume":"11","author":"Kim","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jfda.2018.01.008_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1527-3466.2002.tb00099.x","article-title":"Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor","volume":"20","author":"Olsson","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.jfda.2018.01.008_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/17425255.2014.851667","article-title":"Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin","volume":"10","author":"Hu","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jfda.2018.01.008_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/clpt.2009.197","article-title":"Transporter pharmacogenetics and statin toxicity","volume":"87","author":"Niemi","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jfda.2018.01.008_bib13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/mp200103h","article-title":"pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1","volume":"8","author":"Varma","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jfda.2018.01.008_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2133\/dmpk.DMPK-12-RG-101","article-title":"Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes","volume":"28","author":"Misaka","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jfda.2018.01.008_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.18433\/J3MS5C","article-title":"Inhibitory effects of eight green tea catechins on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activities","volume":"19","author":"Satoh","year":"2016","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.jfda.2018.01.008_bib16","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1124\/dmd.105.005926","article-title":"Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators","volume":"33","author":"Wang","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jfda.2018.01.008_bib17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/dmd.110.036640","article-title":"Interactions of green tea catechins with organic anion-transporting polypeptides","volume":"39","author":"Roth","year":"2011","journal-title":"Drug Meta Dispos"},{"key":"10.1016\/j.jfda.2018.01.008_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-4889(01)00175-6","article-title":"Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols","volume":"1542","author":"Jodoin","year":"2002","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.jfda.2018.01.008_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jff.2011.05.005","article-title":"The ability of gallate and pyrogallol moieties of catechins to inhibit P-glycoprotein function","volume":"3","author":"Sugihara","year":"2011","journal-title":"J Funct Foods"},{"key":"10.1016\/j.jfda.2018.01.008_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139370","article-title":"Inhibitory effects of green tea and (-)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein","volume":"10","author":"Knop","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jfda.2018.01.008_bib21","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1124\/mol.65.5.1208","article-title":"Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport","volume":"65","author":"Zhang","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jfda.2018.01.008_bib22","first-page":"1025","article-title":"Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability","volume":"11","author":"Lee","year":"2002","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.jfda.2018.01.008_bib23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1177\/0091270006294277","article-title":"Grapefruit-drug interactions: can interactions with drugs be avoided?","volume":"46","author":"Mertens-Talcott","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jfda.2018.01.008_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/clpt.2013.241","article-title":"Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects","volume":"95","author":"Misaka","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jfda.2018.01.008_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1536\/ihj.15-459","article-title":"Comparative effectiveness of oral medications for pulmonary arterial hypertension","volume":"57","author":"Igarashi","year":"2016","journal-title":"Int Heart J"},{"key":"10.1016\/j.jfda.2018.01.008_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.eururo.2006.07.015","article-title":"Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient","volume":"50","author":"Montorsi","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.jfda.2018.01.008_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.9734\/BJPR\/2014\/6905","article-title":"The effect of green tea on sildenafil pharmacokinetics in Egyptian healthy volunteers","volume":"4","author":"Hegazy","year":"2014","journal-title":"Br J Pharmaceut Res"},{"key":"10.1016\/j.jfda.2018.01.008_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2125.2001.00318.x","article-title":"Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil","volume":"51","author":"Hyland","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jfda.2018.01.008_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0090-9556(24)15055-6","article-title":"In\u00a0vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions","volume":"28","author":"Warrington","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jfda.2018.01.008_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/004982599238687","article-title":"Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man","volume":"29","author":"Walker","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jfda.2018.01.008_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mcp.2002.121236","article-title":"Effects of grapefruit juice on the pharmacokinetics of sildenafil","volume":"71","author":"Jetter","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jfda.2018.01.008_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2011.05.013","article-title":"Increased plasma levels of tacrolimus after ingestion of green tea","volume":"58","author":"Vischini","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jfda.2018.01.008_bib33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2165\/00003495-199346040-00009","article-title":"Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation","volume":"46","author":"Peters","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.jfda.2018.01.008_bib34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1517\/17425255.2011.570260","article-title":"The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation","volume":"7","author":"Picard","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jfda.2018.01.008_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1345\/aph.18238","article-title":"Probable antagonism of warfarin by green tea","volume":"33","author":"Taylor","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jfda.2018.01.008_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2006.04.003","article-title":"Green tea may inhibit warfarin","volume":"115","author":"Cheng","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jfda.2018.01.008_bib37","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfda.2018.01.008_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1517\/14740338.5.3.433","article-title":"Warfarin and its interactions with foods, herbs and other dietary supplements","volume":"5","author":"Nutescu","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jfda.2018.01.008_bib39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0043-100934","article-title":"An appraisal of drug-drug interactions with Green tea (Camellia sinensis)","volume":"83","author":"Albassam","year":"2017","journal-title":"Planta Med"},{"key":"10.1016\/j.jfda.2018.01.008_bib40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1067\/mcp.2000.110216","article-title":"Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin","volume":"68","author":"Lilja","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jfda.2018.01.008_bib41","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.amjcard.2004.07.080","article-title":"Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors","volume":"94","author":"Jacobson","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981830036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981830036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981830036X?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:34:13Z","timestamp":1751402053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S102194981830036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S102194981830036X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2018.01.008","relation":{},"ISSN":["1021-9498"],"issn-type":[{"value":"1021-9498","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update of green tea interactions with cardiovascular drugs\u00a0and\u00a0putative mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}